Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Congress Boosts Research Funding in Cancer, Alzheimer’s, Precision Medicine, BRAIN Initiative and ‘Superbugs’

Washington, DC, May 2, 2017 — Ariana Eunjung Cha reports in The Washington Post that Congress unveiled a bipartisan budget late Sunday that contains a number of welcome surprises for researchers who had been panicking since March, when President Trump proposed deep funding cuts for science and health.

Under the deal, the National Institutes of Health will get a $2 billion boost in fiscal year 2017, as it did the previous year.

Trump had proposed cutting the NIH budget by about one-fifth, or $6 billion, in a draft 2018 budget.

Here are some of the big research winners:

Cancer Research

An additional $476 million for a total of $5.7 billion is designated for the National Cancer Institute (NCI).

In recent years, the NCI has been investing in research into early detection using blood tests for circulating “biomarkers” of cancer.

Under the previous administration, Vice President Joe Biden led a “cancer moonshot” initiative to bring together experts from government, academia and industry to look for more effective treatments for the disease that claims the lives of about 600,000 Americans each year.

Alzheimer’s Disease Research

Alzheimer’s is now the sixth leading cause of death in the United States, yet it remains a mystery in terms of its cause and possible treatments.

Public health experts expect the number of Americans with Alzheimer’s to increase dramatically in the coming years as baby boomers age into their 70s and 80s.

The new budget sets aside an additional $400 million for a total of $1.39 billion for Alzheimer’s research.

Precision Medicine

The initiative, announced by Obama at his State of the Union address in 2015, gets an additional $120 million for a total of $320 million in the budget.

The idea is to find new ways to tailor treatments to a person’s genetics and other individual characteristics to minimize the guesswork in medicine. The government has been recruiting volunteers to share their information for a giant database that could be the basis for this research.

Combating Superbugs

A total of $463 million is directed for research into new antibiotics for infections resistant to traditional ones.

The Centers for Disease Control and Prevention has warned of potentially catastrophic consequences for the world if new medications or other solutions to these pathogens resistant to current antibiotics aren’t developed soon.

They are such a threat that world leaders held a summit last year to brainstorm solutions.

Obama’s BRAIN Initiative

Another Obama-era initiative, the Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) program, seeks to create a comprehensive guide to the anatomy and functioning of the brain.

The budget includes $110 million for efforts to map the human brain.

Other Areas for Budget Increases

Separately, the budget deal also increases funding from $150 million to $800 million to battle the nation’s opioid epidemic.  These funds will go to the CDC and other government groups fighting addiction.

According to the latest numbers from the CDC, a record 52,000 Americans died from overdoses in 2015, and 80 percent involved the misuse or abuse of opioids.

For the full story, click here.